Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Comprehensive Review of Drug Repurposing Strategies against Known Drug Targets of COVID-19
Ankita Khataniar, Upasana Pathak, Sanchaita Rajkhowa, et al.
COVID (2022) Vol. 2, Iss. 2, pp. 148-167
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates
Liliana Rodrigues, Renata Bento Cunha, Tatiana Vassilevskaia, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2723-2723
Open Access | Times Cited: 67
A systematic review of computational approaches to understand cancer biology for informed drug repurposing
Faheem Ahmed, Anupama Samantasinghar, Afaque Manzoor Soomro, et al.
Journal of Biomedical Informatics (2023) Vol. 142, pp. 104373-104373
Open Access | Times Cited: 35
Innovative applications of artificial intelligence during the COVID-19 pandemic
Chenrui Lv, Wenqiang Guo, Xinyi Yin, et al.
Infectious Medicine (2024) Vol. 3, Iss. 1, pp. 100095-100095
Open Access | Times Cited: 16
Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2
Yiying Xue, Husheng Mei, Yisa Chen, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 11
In vitro and in silico investigation of FDA‐approved drugs to be repurposed against Alzheimer's disease
Didem Akkaya, Gökçe Seyhan, Suat Sarı, et al.
Drug Development Research (2024) Vol. 85, Iss. 3
Closed Access | Times Cited: 4
Understanding the Clinical Use of Levosimendan and Perspectives on its Future in Oncology
Eduarda Ribeiro, Nuno Vale
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1296-1296
Open Access | Times Cited: 11
Drug Discovery and Computational Strategies in Multi-Drug-Resistant Tuberculosis
S. Satish, Nachiket Joshi, Rajasekhar Reddy Alavala, et al.
(2025), pp. 965-997
Closed Access
Drug repurposing against main protease and RNA-dependent RNA polymerase of SARS-CoV-2 using molecular docking, MM-GBSA calculations and molecular dynamics
Ahmed O. Mohammed, Mazin I. Abo-Idrees, Alaa A. Makki, et al.
Structural Chemistry (2022) Vol. 33, Iss. 5, pp. 1553-1567
Open Access | Times Cited: 13
In Vitro Drug Repurposing: Focus on Vasodilators
Eduarda Ribeiro, Bárbara Costa, Francisco Vasques‐Nóvoa, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 671-671
Open Access | Times Cited: 8
Repurposing Benztropine, Natamycin, and Nitazoxanide Using Drug Combination and Characterization of Gastric Cancer Cell Lines
Eduarda Ribeiro, Diana Araújo, Mariana Pereira, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 799-799
Open Access | Times Cited: 6
Repurposing of the Drug Tezosentan for Cancer Therapy
Eduarda Ribeiro, Nuno Vale
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 5118-5131
Open Access | Times Cited: 6
Reimagining old drugs with new tricks: Mechanisms, strategies and notable success stories in drug repurposing for neurological diseases
Neetu Rani, Aastha Kaushik, Shefali Kardam, et al.
Progress in molecular biology and translational science (2024), pp. 23-70
Closed Access | Times Cited: 2
Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects
Eduarda Ribeiro, Nuno Vale
Targets (2024) Vol. 2, Iss. 2, pp. 137-156
Open Access | Times Cited: 2
Will the Use of Pharmacogenetics Improve Treatment Efficiency in COVID-19?
Beata Franczyk, Jacek Rysz, Jarosław Miłoński, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 6, pp. 739-739
Open Access | Times Cited: 10
Plant Spices as a Source of Antimicrobial Synergic Molecules to Treat Bacterial and Viral Co-Infections
Nathália Barroso Almeida Duarte, Jacqueline A. Takahashi
Molecules (2022) Vol. 27, Iss. 23, pp. 8210-8210
Open Access | Times Cited: 10
Using TransR to enhance drug repurposing knowledge graph for COVID-19 and its complications
Hongxi Zhao, Hongfei Li, Qiaoming Liu, et al.
Methods (2023) Vol. 221, pp. 82-90
Closed Access | Times Cited: 5
Inferring molecular mechanisms of host-microbe-drug interactions in the human gastrointestinal tract
B. Roja, S. Saranya, L. Thamanna, et al.
Medicine in Omics (2023) Vol. 10, pp. 100027-100027
Open Access | Times Cited: 5
Forecast of Omicron Wave Time Evolution
R. Schlickeiser, Martin Kröger
COVID (2022) Vol. 2, Iss. 3, pp. 216-229
Open Access | Times Cited: 8
Probing the Action of Screened Anticancer Triazole–Tetrazole Derivatives Against COVID-19 Using Molecular Docking and DFT Investigations
Rageh K. Hussein, Ghada A. Khouqeer, A. Alkaoud, et al.
Natural Product Communications (2022) Vol. 17, Iss. 5, pp. 1934578X2210939-1934578X2210939
Open Access | Times Cited: 8
COVID-19: Vaccines and therapeutics
P. Swapna, Naga Venkata Suryanarayana Birudukota, Ahmed Kamal
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 75, pp. 128987-128987
Open Access | Times Cited: 7
In Silico Screening of Drugs That Target Different Forms of E Protein for Potential Treatment of COVID-19
Gema Lizbeth Ramírez Salinas, Alejandro Lopez‐Rincon, Jazmín García‐Machorro, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 296-296
Open Access | Times Cited: 4
EGeRepDR: An enhanced genetic-based representation learning for drug repurposing using multiple biomedical sources
M. Saranya, Arockia Xavier Annie Rayan, Geetha Thekkumpurath Varrieth
Journal of Biomedical Informatics (2023) Vol. 147, pp. 104528-104528
Closed Access | Times Cited: 4
Two Years of COVID: The Journey to Discover a New Disease
Giuseppe Novelli
COVID (2024) Vol. 4, Iss. 1, pp. 85-86
Open Access | Times Cited: 1
The pattern of antibiotic utilisation among intensive care unit patients hospitalised in a Gauteng (South African) provincial tertiary hospital: Comparing findings before and during COVID-19
L Spinickum, Zelna Booth, Stephanie Leigh‐de Rapper
South African Medical Journal (2024), pp. e1812-e1812
Open Access | Times Cited: 1
Mechanistic Insights into the Mutational Landscape of the Main Protease/3CLPro and Its Impact on Long-Term COVID-19/SARS-CoV-2 Management
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonjabulo Ntombikhona Magwaza, et al.
(2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top